CADL ▲ +1.1% - Candel Therapeutics, Inc.
$CADL - Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
Candel Therapeutics appointed Martine Zimmermann, PharmD, to its board of directors, a move that likely reflected investor confidence in the addition of her pharmaceutical expertise to the company's leadership. The stock rose 1.1% on the announcement.
10-SEP-2026 08:05 AM ET
Share this post
More filings for $CADL
CADL ▼ -2.2% - Candel Therapeutics, Inc.Sep 1, 2026$CADL SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $CADL filing history →💬 Comments
Loading comments…
Leave a comment
